Abstract
Objective
Diabetes mellitus (DM) had been discovered as an independent risk factor for high on-treatment platelet reactivity (HPR) in patients with ischemic stroke. However, studies on the relationship between prediabetes and the occurrence of HPR remain scarce. This study is aimed at clarifying the association between prediabetes and HPR among patients with recent ischemic stroke or transient ischemic stroke (TIA).
Methods
Patients with ischemic stroke or TIA within 90 days after onset were recruited consecutively. All patients were divided into three groups: DM, prediabetes, and normal glucose tolerance according to fasting glucose, HbA1c, or OGTT. Three months later, all patients were performed platelet aggregation inhibition test and screened for high on-treatment platelet reactivity. The effect of prediabetes on HPR was analyzed in a multivariable logistic regression model.
Results
This study recruited 237 patients with ischemic stroke or TIA, including 57 cases with prediabetes, 108 with DM, and 72 with normal glucose tolerance. Aspirin and/or clopidogrel resistance was discovered in 28 cases among prediabetes group, which was significantly more frequent than normal glucose tolerance group(49.1% versus 33.3%, P = 0.046). After adjusting for confounding factors, prediabetes was found as an independent risk factor for high on-treatment platelet reactivity (HPR) among patients with recent ischemic stroke or TIA (odds ratio 2.92; 95% CI, 1.29 to 6.63, P = 0.01).
Conclusions
Prediabetes was an independent risk factor for high on-treatment platelet reactivity in patients with recent ischemic cerebrovascular disease. Patients with prediabetes should be highlighted for the efficacy test of antiplatelet drugs.
Similar content being viewed by others
Data availability
The protocol and the statistical analysis plans are available on reasonable request. Deidentified participant data are not available for legal and ethical reasons.
References
Cai G, Zhou W, Lu Y, Chen P, Lu Z, Fu Y (2016) Aspirin resistance and other aspirin-related concerns. Neurol Sci 37(2):181–189. https://doi.org/10.1007/s10072-015-2412-x
Coignion C, Poli M, Sagnier S, Freyburger G, Renou P, Debruxelles S, Rouanet F, Sibon I (2015) Interest of antiplatelet drug testing after an acute ischemic stroke. Eur Neurol 74(3–4):135–139. https://doi.org/10.1159/000438722
Yi X, Zhou Q, Lin J, Chi L (2013a) Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events. International Journal of Stroke: official Journal of the International Stroke Society 8:535–539. https://doi.org/10.1111/j.1747-4949.2012.00929.x
Floyd CN, Ferro A (2015) Antiplatelet drug resistance: molecular insights and clinical implications. Prostaglandins Other Lipid Mediat 120:21–27. https://doi.org/10.1016/j.prostaglandins.2015.03.011
Laurent B, Udaya ST, Rossella M, Ruediger B, Dominick JA, Richard B, Deepak LB, Marco C, Jean PC, Thomas C, Christian G, Gilles M, Lisa KJ, Dean K, Dirk S, Dietmar T, Jochem WVW, Franck P, Matthew JP, Ron W, Paul AG (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919–933. https://doi.org/10.1016/j.jacc.2010.04.047
Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S (2017) High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis. J Neurol Sci 376:112–116. https://doi.org/10.1016/j.jns.2017.03.010
Kuliczkowski W, Gasior M, Pres D, Kaczmarski J, Laszowska A, Szewczyk M, Hawranek M, Tajstra M, Zeglen S, Polonski L, Serebruany VL (2015) Aspirin ‘resistance’: impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarction. Cardiology 131(1):41–50. https://doi.org/10.1159/000371793
Yi XY, Wang C, Liu P, Fu C, Lin J, Chen YM (2016) Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol 263(8):1612–1619. https://doi.org/10.1007/s00415-016-8181-5
Jia Q, Liu GF, Zheng HG, Zhao XQ, Wang CX, Wang YL, Liu LP, Wang YJ, Gluc ISA (2014) Impaired glucose regulation predicted 1-year mortality of Chinese patients with ischemic stroke data from abnormal glucose regulation in patients with acute stroke across China. Stroke 45(5):1498–1500. https://doi.org/10.1161/Strokeaha.113.002977
Jia Q, Zhao XQ, Wang CX, Wang YL, Yan Y, Li H, Zhong LY, Liu LP, Zheng HG, Zhou Y, Wang YJ (2011) Diabetes and poor outcomes within 6 months after acute ischemic stroke the China National Stroke Registry. Stroke 42(10):2758–2762. https://doi.org/10.1161/Strokeaha.111.621649
Jing J, Pan YS, Zhao XQ, Zheng HG, Jia Q, Mi DH, Chen WQ, Li H, Liu LP, Wang CX, He Y, Wang D, Wang YL, Wang YJ, I. ACROSS-China (2017) Insulin resistance and prognosis of nondiabetic patients with ischemic stroke the ACROSS-China study (abnormal glucose regulation in patients with acute stroke across China). Stroke 48(4):887–893. https://doi.org/10.1161/Strokeaha.116.015613
Pan Y, Chen W, Xu Y, Yi X, Han Y, Yang Q, Li X, Huang L, Johnston SC, Zhao X, Liu L, Zhang Q, Wang G, Wang Y, Wang Y (2017a) Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Circulation 135(1):21–33. https://doi.org/10.1161/CIRCULATIONAHA.116.024913
Pan YS, Jing J, Chen WQ, Zheng HG, Jia Q, Mi DH, Li H, Zhao XQ, Liu LP, Wang CX, Gaisano HY, He Y, Wang YL, Wang YJ (2017b) Post-glucose load measures of insulin resistance and prognosis of nondiabetic patients with ischemic stroke. J Am Heart Assoc 6(1):ARTN e004990. https://doi.org/10.1161/JAHA.116.004990
Frontroth JP (2013) Light transmission aggregometry. Methods Mol Biol 992:227–240. https://doi.org/10.1007/978-1-62703-339-8_17
Hvas AM, Favaloro EJ (2017) Platelet function analyzed by light transmission aggregometry. Methods Mol Biol 1646:321–331. https://doi.org/10.1007/978-1-4939-7196-1_25
Liu L, Gao YH, Cao J, Zhang HX, Fan L, Hu GL (2016) High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome. Journal of geriatric cardiology: JGC 13:531–536. https://doi.org/10.11909/j.issn.1671-5411.2016.06.009
Bobescu E, Covaciu A, Rus H, Rogozea LM, Badea M, Marceanu LG (2020) Low response to clopidogrel in coronary artery disease. Am J Ther 27(2):e133–e141. https://doi.org/10.1097/MJT.0000000000001099
Sharma RK, Voelker DJ, Sharma R (2012) Evolving role of platelet function testing in coronary artery interventions. Vasc Health Risk Manag 8:65–75. https://doi.org/10.2147/VHRM.S28090
Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y, C. investigators (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70–78. https://doi.org/10.1001/jama.2016.8662
Lundstrom A, Laska AC, Von Arbin M, Jorneskog G, Wallen H (2014) Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. Platelets 25(2):102–110. https://doi.org/10.3109/09537104.2013.777951
Masafumi U, Kosuke F, Hiroyuki Y, Tomoyuki I, Tatsuya S, Kenji Y, Shinichiro I, Kazuhiro K, Yoshitaka I, Dominick JA, Shunichi M (2015) Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease. J Thromb Thrombolysis 40(2):174–181. https://doi.org/10.1007/s11239-015-1177-7
Ferreira IA, Mocking AIM, Feijge MAH, Gorter G, van Haeften TW, Heemskerk JWM, Akkerman JWN (2006) Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 26(2):417–422. https://doi.org/10.1161/01.ATV.0000199519.37089.a0
Kakouros N, Rade JJ, Kourliouros A, Resar JR (2011) Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol 2011:742719. https://doi.org/10.1155/2011/742719
Le Guyader A, Pacheco G, Seaver N, Davis-Gorman G, Copeland J, McDonagh PF (2009) Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia. J Diabetes Complicat 23(1):65–70. https://doi.org/10.1016/j.jdiacomp.2007.06.003
Russo I, Viretto M, Barale C, Mattiello L, Doronzo G, Pagliarino A, Cavalot F, Trovati M, Anfossi G (2012) High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets. Diabetes 61(11):2913–2921. https://doi.org/10.2337/db12-0040
Stroke 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders. Stroke 20(10): 1407–1431. https://doi.org/10.1161/01.str.20.10.1407
Al-Jabi SW (2017) Global trends in aspirin resistance-related research from 1990 to 2015: a bibliometric analysis. Basic Clin Pharmacol Toxicol 121(6):512–519. https://doi.org/10.1111/bcpt.12840
Funding
This study was funded by National Key Research and Development Program of the Ministry of Science and Technology of The People’s Republic of China (2018YFC1312303, 2016YFC1301604, 2018YFC1705003, 2018YFC2002302).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Weili Jia and Qian Jia. The first draft of the manuscript was written by Weili Jia, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest pertaining to this paper.
Ethics approval
This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the Ethics Committee at Beijing Tiantan Hospital approved this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jia, W., Jia, Q., Zhang, Y. et al. Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA. Neurol Sci 42, 2829–2835 (2021). https://doi.org/10.1007/s10072-020-04881-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04881-w